Explore how deep learning enables automated extraction of NYHA classes and heart failure symptoms, enhancing heart failure ...
We hypothesized that chronic heart failure patients with NYHA functional class II symptoms, right ventricular pacing, or QRS duration of less than or equal to 150 ms will also benefit from CRT.
About 96% of the patients had NYHA class III symptoms. The mean LVEF was 25.6%; CHF was ischemic in etiology in 61% of the patients. More than 99% of the patients were on optimal medical therapy ...
By targeting the TTR gene directly in the liver, the therapy “has opened up the door” to permanent treatment, says Sarah ...
The designation is for AB-1002 (also known as NAN-101) as a one-shot therapy for adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) class III heart failure symptoms ...